RGT — Argent BioPharma Share News
0.000.00%
- AU$3.17m
- AU$3.02m
- AU$0.18m
Director/PDMR Shareholding
Refinancing of Convertible Security Agreement
Annual Report for the year ended 30 June 2024
Date of AGM & Closing Date of Director Nominations
ASX Delisting Update
Director/PDMR Shareholding
CannEpil - Technical Overview
CimetrA - Technical Overview
30 June 2024 Preliminary Financial Report
Notice of General Meeting
SINTEF Collaboration for Chronic Wound Management
Brief: Argent Biopharma Says ASX Provided Formal Approval For Co To Delist From ASX
Brief: Argent Biopharma Seeks Trading Halt
June 2024 Quarter Activity Report and Cash Flow
Placing to Raise US$2,000,000
Brief: Argent Biopharma Says Placing To Raise $2 Million
Brief: Argent Biopharma Seeks Trading Halt
Placing to Raise US$500,000
Brief: Argent Biopharma Seeks Trading Halt